[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Impact Factor 2022: 1.4
Cite Score 2022: 2.1
SJR 2022: 0.347
SNIP 2022: 0.545
..
Publication Charge
►Publication Fee
..
In Press
 In Press Articles
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 13 - Covid 19 Supplement 2 ::
Caspian J Intern Med 2022, 13 - Covid 19 Supplement 2: 199-203 Back to browse issues page
Effects of the COVID-19 Pandemic on Treatment Adherence in Patients with Chronic Heart Failure
Sergey Yu. Martsevich , Yulia V. Lukina , Natalia P. Kutishenko , Elmira T. Guseynova
Department of Preventive Pharmacotherapy, National Medical Research Center for Therapy and Preventive Medicine, Petroverigsky per. 10, Moscow, Russia , e.guseinova@mail.ru
Abstract:   (1941 Views)
Background: To assess the influence of the COVID-19 (Coronavirus Disease 2019) pandemic on treatment adherence by patients with CHF (Chronic heart failure) and to determine the factors associated with changing adherence during home-isolation.
Methods: The survey was conducted in patients participating in the COMPLIANCE study (ClinicalTrials.gov. NCT04262583). Thirty-one patients, included into the COMPLIANCE study before March 1, 2020, were interviewed through phone calls. A modified adherence scale of the National Society for Evidence-Based Pharmacotherapy was used, which permits to assess overall adherence, adherence to particular drugs and the main causes for non-adherence.
Results: In the whole group of patients, only a tendency to reduced overall adherence was registered during the COVID-19 pandemic (р=0,256). Significant differences in the rate of adherence deterioration were revealed for angiotensin-converting enzyme (ACE) inhibitors (p=0.031) and for statins (p=0.002). The reasons for non-adherence were lack of opportunity to contact with physician, inability to perform investigations necessary for correcting prescribed pharmacotherapy, and side effects.
Conclusion: A tendency to deterioration of adherence to prescribed pharmacotherapy was revealed during the COVID-19 pandemic. A significant decline in adherence was registered to ACE-inhibitors and statins.
Keywords: adherence to treatment, period of home-isolation, COVID-19, chronic heart failure, factors of non- adherence
Full-Text [PDF 246 kb]   (703 Downloads)    
Type of Study: Original Article | Subject: Cardiology
Received: 2021/01/4 | Accepted: 2021/09/11 | Published: 2022/04/6
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Martsevich S Y, Lukina Y V, Kutishenko N P, Guseynova E T. Effects of the COVID-19 Pandemic on Treatment Adherence in Patients with Chronic Heart Failure. Caspian J Intern Med 2022; 13 :199-203
URL: http://caspjim.com/article-1-2689-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 13 - Covid 19 Supplement 2 Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.05 seconds with 40 queries by YEKTAWEB 4645